Skip to content
Home/Companies/Biotech/Phaeosynt GmbH

Phaeosynt GmbH

Biotech·Germany·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Phaeosynt GmbH?

Phaeosynt GmbH is a German Biotech company, currently owned by NBank Capital since 2025.

Hand-verified · updated 2026-07-07

Open JSON · CC-BY
NBank Capital
Investor
NBank Capital
NBank Capital Beteiligungsfonds · 2009 · Evergreen

Key facts

HQGermany
SectorBiotech
StatusActive

More from NBank Capital Beteiligungsfonds

Other portfolio companies in the same fund.

ALL About Midlife
Active
Germany· 2026
FEHRMANN MaterialsX GmbH
Active
Germany· 2026
Herodikos
Active
Germany· 2026
BIOWEG GmbH
Active
ClimateTechGermany· 2025
heyGuide (formerly heyParents)
Active
Germany· 2025
LBR Manufacturing GmbH
Active
Germany· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Phaeosynt GmbH?

Phaeosynt GmbH is currently owned by NBank Capital, through NBank Capital Beteiligungsfonds, since 2025.

When did NBank Capital acquire Phaeosynt GmbH?

NBank Capital acquired Phaeosynt GmbH in 2025.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue